Adv Drug Deliv Rev. 2006 Oct 1;58(8):916-30. Epub 2006 Aug 12.

Improved peptide vaccine strategies, creating synthetic artificial infections to maximize immune efficacy.

van der Burg SH, Bijker MS, Welters MJ, Offringa R, Melief CJ.

Source

Department of Clinical Oncology, Leiden University Medical Centre, Albinusdreef 2, 2333 ZA Leiden, The Netherlands. S.H.van_der_Burg@lumc.nl

Abstract

Soon after it was realized that T-cells recognize their target antigens as small protein fragments or peptides presented by MHC molecules at the cell surface, these peptide epitopes have been tried as vaccines. Human testing of such vaccines, although protective in mouse models, has produced mixed results. Since these initial trials, there has been an tremendous increase in our understanding of how infectious organisms can induce potent immune responses. In this article we review the key changes in the design, formulation and delivery of synthetic peptide vaccines that are applied to improve peptide vaccine strategies.

PMID:: 16979788; [PubMed - indexed for MEDLINE]

Publication Types, MeSH Terms, Substances

Publication Types

Review

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources

Labome Researcher Resource - ExactAntigen/Labome

Medical

Cancer - MedlinePlus Health Information

Supplemental Content

Save items

Related citations in PubMed

Review Next-generation peptide vaccines for advanced cancer. [Cancer Sci. 2013]
Review Next-generation peptide vaccines for advanced cancer.
Yamada A, Sasada T, Noguchi M, Itoh K. Cancer Sci. 2013 Jan; 104(1):15-21. Epub 2012 Dec 4.
Induction of multiepitopic and long-lasting immune responses against tumour antigens by immunization with peptides, DNA and recombinant adenoviruses expressing minigenes. [Scand J Immunol. 2009]
Induction of multiepitopic and long-lasting immune responses against tumour antigens by immunization with peptides, DNA and recombinant adenoviruses expressing minigenes.
Durántez M, López-Vázquez AB, de Cerio AL, Huarte E, Casares N, Prieto J, Borrás-Cuesta F, Lasarte JJ, Sarobe P. Scand J Immunol. 2009 Feb; 69(2):80-9. Epub 2008 Dec 10.
Review [Development for a novel cancer vaccine]. [Gan To Kagaku Ryoho. 2004]
Review [Development for a novel cancer vaccine].
Tsunoda T. Gan To Kagaku Ryoho. 2004 Dec; 31(13):2095-9.
Review T-cell epitope peptide vaccines. [Expert Rev Vaccines. 2004]
Review T-cell epitope peptide vaccines.
Elsawa SF, Rodeberg DA, Celis E. Expert Rev Vaccines. 2004 Oct; 3(5):563-75.
Review Epitope selection and development of peptide based vaccines to treat cancer. [Semin Cancer Biol. 1995]
Review Epitope selection and development of peptide based vaccines to treat cancer.
Celis E, Sette A, Grey HM. Semin Cancer Biol. 1995 Dec; 6(6):329-36.

See reviews... See all...

Cited by 7 PubMed Central articles

Tumor Inhibition by DepoVax-Based Cancer Vaccine Is Accompanied by Reduced Regulatory/Suppressor Cell Proliferation and Tumor Infiltration. [ISRN Oncol. 2013]
Tumor Inhibition by DepoVax-Based Cancer Vaccine Is Accompanied by Reduced Regulatory/Suppressor Cell Proliferation and Tumor Infiltration.
Karkada M, Quinton T, Blackman R, Mansour M. ISRN Oncol. 2013; 2013:753427. Epub 2013 Mar 7.
Inclusion of a specific T cell epitope increases the protection conferred against foot-and-mouth disease virus in pigs by a linear peptide containing an immunodominant B cell site. [Virol J. 2012]
Inclusion of a specific T cell epitope increases the protection conferred against foot-and-mouth disease virus in pigs by a linear peptide containing an immunodominant B cell site.
Cubillos C, de la Torre BG, Bárcena J, Andreu D, Sobrino F, Blanco E. Virol J. 2012 Mar 14; 9:66. Epub 2012 Mar 14.
Review Immunological and clinical effects of vaccines targeting p53-overexpressing malignancies. [J Biomed Biotechnol. 2011]
Review Immunological and clinical effects of vaccines targeting p53-overexpressing malignancies.
Vermeij R, Leffers N, van der Burg SH, Melief CJ, Daemen T, Nijman HW. J Biomed Biotechnol. 2011; 2011:702146. Epub 2011 Mar 15.

See all...

Recent activity

Clear Turn Off Turn On

Improved peptide vaccine strategies, creating synthetic artificial infections to...
Improved peptide vaccine strategies, creating synthetic artificial infections to maximize immune efficacy.
Adv Drug Deliv Rev. 2006 Oct 1 ;58(8):916-30. Epub 2006 Aug 12 .

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to: